ArticleFuture science OA2019
Survival and glycemic control in patients with coexisting melanoma and diabetes mellitus.
Article in Future science OA, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 8 citations in OpenAlex.
- Causes of death among patients with cutaneous melanoma: a US population-based study.Scientific reports · 2023Article
- Cancer, diabetes, survival and glycemic control: a large multisite analysis.Future science OA · 2022Article
- Implications of neuroendocrine tumor and diabetes mellitus on patient outcomes and care: a matched case-control study.Future science OA · 2021Article
- Survival and glycemic control in patients with co-existing squamous cell carcinoma and diabetes mellitus.Future science OA · 2021Article
- Mortality and glycemic control among patients with diabetes mellitus and uterine or ovarian cancer.Future science OA · 2020Article
- Survival and glycemic control in patients with coexisting lymphoma and diabetes: a case-control analysis.Future science OA · 2020Article
- Mortality and glycemic control among patients with acute and chronic myeloid leukemia and diabetes: a case-control study.Future science OA · 2020Article
- Role of Insulin Use and Social Determinants of Health on Non-melanoma Skin Cancer: Results From the Behavioral Risk Factor Surveillance System.Cancer control : journal of the Moffitt Cancer CenterArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimGiven the lack of data in the literature, we examined the impact of diabetes mellitus (DM) on melanoma survival and the impact of melanoma on glycemic control. MATERIALS &
methodsPatients with melanoma with and without DM were matched 1:1 (2005-2016). Kaplan-Meier analysis was used to estimate overall survival and progression-free survival (PFS). Mixed models compared hemoglobin A
resultsMean HbA
conclusionMelanoma did not adversely impact glycemic control. The DM did not adversely impact survival of patients with melanoma, although increased PFS for melanoma was seen in individuals with DM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.